Viewing StudyNCT05413421



Ignite Creation Date: 2024-05-06 @ 5:45 PM
Last Modification Date: 2024-10-26 @ 2:34 PM
Study NCT ID: NCT05413421
Status: RECRUITING
Last Update Posted: 2023-05-03
First Post: 2022-06-07

Brief Title: Study of ORIC-944 in Patients with Metastatic Prostate Cancer
Sponsor: ORIC Pharmaceuticals
Organization: ORIC Pharmaceuticals

Conditions & Keywords Data

Conditions:
Name
Neuroendocrine Prostate Cancer
Metastatic Prostate Cancer
Keywords:
Name View
CRPC View
PRC2 dysregulation View
EED View